| RE48547 |
Aminopyrimidinecarboxamides as CXCR2 modulators |
Dean Y. Maeda, John A. Zebala |
2021-05-11 |
| 10993953 |
Method for treating cancer using chemokine antagonists |
John A. Zebala, Dean Y. Maeda |
2021-05-04 |
| 10660909 |
Method for treating cancer using chemokine antagonists |
John A. Zebala, Dean Y. Maeda |
2020-05-26 |
| RE47740 |
Aminopyridinecarboxamides as CXCR2 modulators |
Dean Y. Maeda, John A. Zebala |
2019-11-26 |
| 10130645 |
Use of thiopyrimidinecarboxamide for treating cancer |
John A. Zebala, Dean Y. Maeda |
2018-11-20 |
| 10046002 |
Method for treating cancer using chemokine antagonists |
John A. Zebala, Dean Y. Maeda |
2018-08-14 |
| 9707248 |
Use of thiopyrimidinecarboxamide for treating cancer |
John A. Zebala, Dean Y. Maeda |
2017-07-18 |
| 9480694 |
Thiopyrimidinecarboxamide for use in treating pulmonary disease |
John A. Zebala, Dean Y. Maeda |
2016-11-01 |
| 8993541 |
Aminopyrimidinecarboxamides as CXCR2 modulators |
Dean Y. Maeda, John A. Zebala |
2015-03-31 |
| 8969365 |
Thiopyrimidinecarboxamides as CXCR1/2 modulators |
Dean Y. Maeda, John A. Zebala |
2015-03-03 |
| 8779149 |
Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators |
Dean Y. Maeda, John A. Zebala |
2014-07-15 |